Firms
Theme

EVR

Evercore Inc. · NYSE

News

3 latest

Zacks Investment Research

BGC vs. EVR: Which Stock Is the Better Value Option?

A comparison of two Financial-Investment Bank sector stocks reveals BGC Group as the superior value opportunity. BGC holds a Zacks Rank #2 (Buy) with a forward P/E of 8.30 and PEG ratio of 0.42, while Evercore carries a Zacks Rank #5 (Strong Sell) with a forward P/E of 13.86 and PEG ratio of 1.14. BGC's improving earnings outlook and stronger valuation metrics make it the preferred choice for value investors.

Zacks Investment Research

Analysts Estimate Evercore (EVR) to Report a Decline in Earnings: What to Look Out for

Evercore is expected to report a year-over-year decline in earnings and revenues for Q3 2026, with EPS estimated at $2.61 (down 25%) and revenues at $916.49 million (down 12.5%). The stock carries a Zacks Rank #5 and an Earnings ESP of 0%, making it difficult to predict an earnings beat. The company missed consensus estimates in the last quarter by 3.64%.

Zacks Investment Research

Bear of the Day: Evercore (EVR)

Evercore (EVR) has been downgraded to a Zacks Rank #5 (Strong Sell) as earnings estimates decline sharply and the stock falls 25% year-to-date. FY26 and FY27 EPS estimates have dropped 7% and 6% respectively, while Q3 estimates plunged 23% in one week. Rising Treasury yields above 5.3% and higher interest rates threaten investment banking activity and dealmaking, pressuring the firm's advisory and underwriting revenue.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $EVR · 0 threads

Sign in to post on $EVR

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev